Albemarle ALB has been analyzed by 16 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 4 | 10 | 1 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 1 | 2 | 0 | 0 |
| 3M Ago | 1 | 3 | 7 | 1 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $103.25, a high estimate of $170.00, and a low estimate of $78.00. A decline of 21.18% from the prior average price target is evident in the current average.
Interpreting Analyst Ratings: A Closer Look
A comprehensive examination of how financial experts perceive Albemarle is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Michael Sison | Wells Fargo | Raises | Equal-Weight | $110.00 | $100.00 |
| Stephen Richardson | Evercore ISI Group | Lowers | Outperform | $170.00 | $190.00 |
| Jeffrey Zekauskas | JP Morgan | Lowers | Neutral | $78.00 | $115.00 |
| Corinne Blanchard | Deutsche Bank | Lowers | Hold | $80.00 | $105.00 |
| Charles Neivert | Piper Sandler | Lowers | Underweight | $90.00 | $95.00 |
| Ben Isaacson | Scotiabank | Lowers | Sector Perform | $85.00 | $135.00 |
| Arun Viswanathan | RBC Capital | Lowers | Outperform | $111.00 | $128.00 |
| Aleksey Yefremov | Keybanc | Lowers | Overweight | $132.00 | $151.00 |
| Ben Kallo | Baird | Lowers | Neutral | $85.00 | $102.00 |
| Matthew DeYoe | B of A Securities | Lowers | Buy | $126.00 | $135.00 |
| Ben Kallo | Baird | Lowers | Outperform | $102.00 | $127.00 |
| Andres Castanos Mollor | Berenberg | Lowers | Hold | $83.00 | $160.00 |
| Corinne Blanchard | Deutsche Bank | Lowers | Hold | $105.00 | $140.00 |
| Santhosh Seshadri | HSBC | Announces | Hold | $95.00 | - |
| Patrick Cunningham | Citigroup | Lowers | Neutral | $100.00 | $137.00 |
| Michael Sison | Wells Fargo | Lowers | Equal-Weight | $100.00 | $145.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Albemarle. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Albemarle compared to the broader market.
- Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.
To gain a panoramic view of Albemarle's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Albemarle analyst ratings.
Discovering Albemarle: A Closer Look
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.
Understanding the Numbers: Albemarle's Finances
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Negative Revenue Trend: Examining Albemarle's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -39.65% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Materials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Albemarle's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -16.07%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Albemarle's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -2.51%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Albemarle's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -1.23%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Albemarle's debt-to-equity ratio is below the industry average at 0.39, reflecting a lower dependency on debt financing and a more conservative financial approach.
Analyst Ratings: What Are They?
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
